-
MEXIDOL® (Emoxipine) 125 mg, 50 coated tablets
$17.00
$22.00 -
ARPEFLU (Umifenovir) 100 mg, 20/30 caps
$24.00 – $33.00
Keltikan 3’s lyophilized powder for quality in with the solvent solution
$18.50
Description
The instruction for medical use of Keltikan® medicine the Trade name of Keltikan® the International unlicensed name Is not present the Dosage form the Powder lyophilized for preparation of solution for injections complete with the Structure One Ampoule solvent contains active agents: – cytidine-5 dinatrium monophosphate of 10 mg uridine 5 ´-trisodium triphosphate, uridine 5´ – dinatrium diphosphate, uridine 5 ´-dinatrium monophosphate (totally) 6 mg (it is equivalent uridine) 2.66 mg, excipient – Mannitolum. Composition of solvent: chloride sodium, water for injections. The description the Lyophilized hygroscopic powder of white color in the form of disks. Solvent – flavourless transparent colourless liquid. Pharmacotherapeutic group Drugs for treatment of diseases of the musculoskeletal system others. Drugs for treatment of diseases of the musculoskeletal system others. The ATH M09AX code the Pharmacological Pharmacokinetics of Keltikan® properties is a combination of two nucleotides – cytidine of monophosphate and uridine of triphosphate. These nucleotides are present at an organism therefore it is not possible to conduct a typical pharmacokinetic research. The pharmacodynamics of Keltikan® provides an organism with the phosphatic groups necessary for association of monosaccharides with Keraminums for forming of nervous covers, and the fosfatidny acids making sphingomyelin and glycerophospholipids – the main components of a myelin cover. Thus, the steady trophic effect, fuller maturing and regeneration of axonal nerve fibrils is provided. Therefore inflammation decreases and the sensitivity of the damaged site of an axon is normalized that promotes restoration of axonal transport. Indications sciaticas (lumbago, a lyumbalgiya, a lumbar ishialgia) a diabetic polyneuropathy poluneuritis potatorum shingles, a ganglionitis an epileptiform neuralgia of a neuropathy (neuralgia) front and intercostal nerves plexites the Route of administration and doses of Keltikan®, an injection is entered intramusculary. It is necessary to add ampoule contents with solvent to an ampoule with powder, to mix before full dissolution. Adults: 1 injection (2 ml) once a day. Children since 2 years: 1 ml of solution (1/2 ampoules) once a day or 1 injection (2 ml) of 1 times in 2 days. Duration of treatment is defined by the doctor depending on a condition of the patient and treatment response. Side effects it was Not described. Manifestation of allergic reactions, in case of manifestation of any undesirable phenomena is possible, it is necessary to suspend reception and it is obligatory to see a doctor. Contraindications hypersensitivity to drug components. children’s age up to 2 years the Medicinal interactions are not established. The special instructions Pregnancy and the period of a lactation Use of drug during pregnancy and a lactation is not established. Pregnant women and women in the period of a lactation should appoint drug only when the expected advantage for mother exceeds possible risk for the fruit/child. Features of influence of medicine on ability to run the vehicle or potentially dangerous mechanisms the Overdose does not influence Considering small toxicity of a product, even when therapeutic doses were accidentally exceeded, intoxication drug is improbable. At accidental overdose, it is necessary to begin symptomatic treatment. The form of release and packing place the Powder lyophilized in glass ampoules of dark yellow color with a notch in the form of a rim. On 2 ml of solvent spill in colourless glass ampoules with a notch in the form of a rim. On 3 ampoules with drug and 3 ampoules with solvent place in blister strip packaging. 1 strip packaging together with the instruction for medical use in the state and Russian languages is put in a cardboard box. To Store storage conditions at a temperature not above 30 °C. To store out of children’s reach! 2 years not to apply a period of storage after an expiration date. Prescription status According to the prescription the Producer/packer Ferrer Internasyonal, S.A., Barcelona, Spain the Owner of the registration certificate Ferrer Internasyonal, S.A., Spain the Address of the organization accepting in the territory of the Republic of Kazakhstan claims from consumers on quality of products (goods): Representative office Takeda Osteuropa Holding GmbH (Austria) in Kazakhstan
Reviews
There are no reviews yet.